Foundry Partners LLC Lowers Stake in UnitedHealth Group Incorporated (UNH)

Foundry Partners LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 33.2% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 3,315 shares of the healthcare conglomerate’s stock after selling 1,650 shares during the period. Foundry Partners LLC’s holdings in UnitedHealth Group were worth $615,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Patriot Financial Group Insurance Agency LLC increased its stake in shares of UnitedHealth Group by 1,722.9% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares during the period. Kings Point Capital Management increased its stake in shares of UnitedHealth Group by 27.9% in the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the period. Founders Capital Management acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at $135,000. Parkside Financial Bank & Trust increased its stake in shares of UnitedHealth Group by 1.4% in the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares during the period. Finally, Hanson McClain Inc. increased its stake in shares of UnitedHealth Group by 1.7% in the 1st quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after buying an additional 15 shares during the period. 86.19% of the stock is owned by institutional investors.

In other news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares in the company, valued at approximately $12,135,774.66. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the sale, the insider now owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 76,174 shares of company stock valued at $14,981,909. Company insiders own 0.89% of the company’s stock.

UnitedHealth Group Incorporated (NYSE:UNH) opened at 194.68 on Wednesday. The company has a market capitalization of $188.23 billion, a price-to-earnings ratio of 23.39 and a beta of 0.63. UnitedHealth Group Incorporated has a 12-month low of $133.03 and a 12-month high of $200.76. The firm’s 50-day moving average price is $196.59 and its 200 day moving average price is $184.23.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same period last year, the business posted $1.96 EPS. The business’s revenue was up 7.7% compared to the same quarter last year. On average, analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were issued a dividend of $0.75 per share. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s payout ratio is currently 35.13%.

TRADEMARK VIOLATION WARNING: “Foundry Partners LLC Lowers Stake in UnitedHealth Group Incorporated (UNH)” was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://ledgergazette.com/2017/10/11/foundry-partners-llc-lowers-stake-in-unitedhealth-group-incorporated-unh.html.

Several research firms have recently commented on UNH. Sanford C. Bernstein reissued an “outperform” rating and issued a $210.00 target price on shares of UnitedHealth Group in a research note on Tuesday. Cowen and Company reaffirmed an “outperform” rating and set a $220.00 price objective (up from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday. Morgan Stanley lifted their price objective

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Patriot Financial Group Insurance Agency LLC increased its stake in shares of UnitedHealth Group by 1,722.9% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares during the period. Kings Point Capital Management increased its stake in shares of UnitedHealth Group by 27.9% in the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the period. Founders Capital Management acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at $135,000. Parkside Financial Bank & Trust increased its stake in shares of UnitedHealth Group by 1.4% in the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares during the period. Finally, Hanson McClain Inc. increased its stake in shares of UnitedHealth Group by 1.7% in the 1st quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after buying an additional 15 shares during the period. 86.19% of the stock is owned by institutional investors.

In other news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares in the company, valued at approximately $12,135,774.66. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the sale, the insider now owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 76,174 shares of company stock valued at $14,981,909. Company insiders own 0.89% of the company’s stock.

UnitedHealth Group Incorporated (NYSE:UNH) opened at 194.68 on Wednesday. The company has a market capitalization of $188.23 billion, a price-to-earnings ratio of 23.39 and a beta of 0.63. UnitedHealth Group Incorporated has a 12-month low of $133.03 and a 12-month high of $200.76. The firm’s 50-day moving average price is $196.59 and its 200 day moving average price is $184.23.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same period last year, the business posted $1.96 EPS. The business’s revenue was up 7.7% compared to the same quarter last year. On average, analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were issued a dividend of $0.75 per share. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s payout ratio is currently 35.13%.

TRADEMARK VIOLATION WARNING: “Foundry Partners LLC Lowers Stake in UnitedHealth Group Incorporated (UNH)” was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://ledgergazette.com/2017/10/11/foundry-partners-llc-lowers-stake-in-unitedhealth-group-incorporated-unh.html.

Several research firms have recently commented on UNH. Sanford C. Bernstein reissued an “outperform” rating and issued a $210.00 target price on shares of UnitedHealth Group in a research note on Tuesday. Cowen and Company reaffirmed an “outperform” rating and set a $220.00 price objective (up from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday. Morgan Stanley lifted their price objective on UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Thursday, August 17th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $215.00 price objective on shares of UnitedHealth Group in a research note on Friday, August 18th. Three research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $203.59.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply